Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Asia Pacific Organ-on-Chip Market


Asia Pacific Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity

Report code: SDMRHE1597483 | Industry: Healthcare and Social Assistance | Published On: 44407


Asia Pacific organ-on-chip market will grow by 35.1% annually with a total addressable market cap of $399.4 million over 2021-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments.
Highlighted with 30 tables and 50 figures, this 105-page report “Asia Pacific Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific organ-on-chip market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific organ-on-chip market in every aspect of the classification from perspectives of Offering, Organ Type, Material, Application, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Chips
• Service

Based on Organ Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liver-on-a-Chip
• Heart-on-a-Chip
• Lung-on-a-Chip
• Kidney-on-a-Chip
• Brain-on-a-Chip
• Skin-on-a-Chip
• Vessels-on-a-Chip
• Other Organ Types

Based on Material, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymers
• Glass
• Silicon

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Drug Discovery
• Toxicology Research
• Other Applications

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Cosmetics Industry
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Organ Type, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AxoSim Inc.
BiomimX SRL
Cherry Biotech
CN Bio Innovations, Ltd.
Emulate Inc.
Hurel Corporation
InSphero AG
Kirkstall, Ltd.
MIMETAS BV
Nortis Inc.
Organovo, Inc.
SynVivo, Inc.
Tara Biosystems Inc.
TissUse GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 7
1.1  Industry  Definition  and  Research  Scope 7
1.1.1  Industry  Definition 7
1.1.2  Research  Scope 8
1.2  Research  Methodology 11
1.2.1  Overview  of  Market  Research  Methodology 11
1.2.2  Market  Assumption 12
1.2.3  Secondary  Data 12
1.2.4  Primary  Data 12
1.2.5  Data  Filtration  and  Model  Design 13
1.2.6  Market  Size/Share  Estimation 14
1.2.7  Research  Limitations 15
1.3  Executive  Summary 16
2  Market  Overview  and  Dynamics 19
2.1  Market  Size  and  Forecast 19
2.1.1  Impact  of  COVID-19  on  World  Economy 20
2.1.2  Impact  of  COVID-19  on  the  Market 22
2.2  Major  Growth  Drivers 24
2.3  Market  Restraints  and  Challenges 29
2.4  Emerging  Opportunities  and  Market  Trends 32
2.5  Porter’s  Fiver  Forces  Analysis 36
3  Segmentation  of  Asia  Pacific  Market  by  Offering 40
3.1  Market  Overview  by  Offering 40
3.2  Chips 42
3.3  Service 43
4  Segmentation  of  Asia  Pacific  Market  by  Organ  Type 44
4.1  Market  Overview  by  Organ  Type 44
4.2  Liver-on-a-Chip 46
4.3  Heart-on-a-Chip 47
4.4  Lung-on-a-Chip 48
4.5  Kidney-on-a-Chip 49
4.6  Brain-on-a-Chip 50
4.7  Skin-on-a-Chip 51
4.8  Vessels-on-a-Chip 52
4.9  Other  Organ  Types 53
5  Segmentation  of  Asia  Pacific  Market  by  Material 54
5.1  Market  Overview  by  Material 54
5.2  Polymers 56
5.3  Glass 57
5.4  Silicon 58
6  Segmentation  of  Asia  Pacific  Market  by  Application 59
6.1  Market  Overview  by  Application 59
6.2  Drug  Discovery 61
6.3  Toxicology  Research 62
6.4  Other  Applications 63
7  Segmentation  of  Asia  Pacific  Market  by  End  User 64
7.1  Market  Overview  by  End  User 64
7.2  Pharmaceutical  and  Biotechnology  Companies 66
7.3  Academic  and  Research  Institutes 67
7.4  Cosmetics  Industry 68
7.5  Other  End  Users 69
8  Asia-Pacific  Market  2019-2030  by  Country 70
8.1  Overview  of  Asia-Pacific  Market 70
8.2  Japan 73
8.3  China 76
8.4  Australia 78
8.5  India 80
8.6  South  Korea 82
8.7  Rest  of  APAC  Region 84
9  Competitive  Landscape 86
9.1  Overview  of  Key  Vendors 86
9.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 89
9.3  Company  Profiles 90
AxoSim  Inc. 90
BiomimX  SRL 92
Cherry  Biotech 93
CN  Bio  Innovations,  Ltd. 94
Emulate  Inc. 95
Hurel  Corporation 96
InSphero  AG 97
Kirkstall,  Ltd. 98
MIMETAS  BV 99
Nortis  Inc. 100
Organovo,  Inc. 101
SynVivo,  Inc. 102
Tara  Biosystems  Inc. 103
TissUse  GmbH 104
RELATED  REPORTS 105
Table 1. Snapshot of Asia Pacific Organ-on-Chip Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Organ-on-Chip Market 32
Table 5. Asia Pacific Organ-on-Chip Market by Offering, 2019-2030, $ mn 40
Table 6. Asia Pacific Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 44
Table 7. Asia Pacific Organ-on-Chip Market by Material, 2019-2030, $ mn 54
Table 8. Asia Pacific Organ-on-Chip Market by Application, 2019-2030, $ mn 59
Table 9. Asia Pacific Organ-on-Chip Market by End User, 2019-2030, $ mn 64
Table 10. APAC Organ-on-Chip Market by Country, 2019-2030, $ mn 71
Table 11. Japan Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 75
Table 12. Japan Organ-on-Chip Market by Application, 2019-2030, $ mn 75
Table 13. Japan Organ-on-Chip Market by End User, 2019-2030, $ mn 75
Table 14. China Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 77
Table 15. China Organ-on-Chip Market by Application, 2019-2030, $ mn 77
Table 16. China Organ-on-Chip Market by End User, 2019-2030, $ mn 77
Table 17. Australia Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 79
Table 18. Australia Organ-on-Chip Market by Application, 2019-2030, $ mn 79
Table 19. Australia Organ-on-Chip Market by End User, 2019-2030, $ mn 79
Table 20. India Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 81
Table 21. India Organ-on-Chip Market by Application, 2019-2030, $ mn 81
Table 22. India Organ-on-Chip Market by End User, 2019-2030, $ mn 81
Table 23. South Korea Organ-on-Chip Market by Organ Type, 2019-2030, $ mn 83
Table 24. South Korea Organ-on-Chip Market by Application, 2019-2030, $ mn 83
Table 25. South Korea Organ-on-Chip Market by End User, 2019-2030, $ mn 83
Table 26. Organ-on-Chip Market in Rest of APAC by Country/Region, 2019-2030, $ mn 85
Table 27. AxoSim Inc.: Company Snapshot 90
Table 28. AxoSim Inc.: Business Segmentation 90
Table 29. AxoSim Inc.: Product Portfolio 91
Table 30. AxoSim Inc.: Revenue, 2017-2019, $ mn 91
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT